Armistice Capital »

Gitlab shares owned by Armistice Capital

Quarter-by-quarter ownership of Gitlab (GTLB) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Gitlab

Tip: Access up to 7 years of quarterly data

All positions including Gitlab held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gitlab by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $22M 1.0M 21.64
2025-09-30 $17M 377k 45.08

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Gitlab

Vanguard Group
Vanguard Portfolio Management
AQR Capital Management
BlackRock
Eminence Capital
PRIMECAP Management Company
Vanguard Capital Management
Slate Path Capital
Susquehanna International
Jane Street
HMI Capital
Impactive Capital
Squarepoint Ops
Champlain Investment Partners
Two Sigma Investments

View all funds holding Gitlab